These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical Experience with [ Alan-Selcuk N; Beydagi G; Demirci E; Ocak M; Celik S; Oven BB; Toklu T; Karaaslan I; Akcay K; Sonmez O; Kabasakal L J Nucl Med; 2023 Oct; 64(10):1574-1580. PubMed ID: 37620050 [TBL] [Abstract][Full Text] [Related]
11. Sathekge M; Bruchertseifer F; Knoesen O; Reyneke F; Lawal I; Lengana T; Davis C; Mahapane J; Corbett C; Vorster M; Morgenstern A Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):129-138. PubMed ID: 30232539 [TBL] [Abstract][Full Text] [Related]
12. The Role of Theranostics in Prostate Cancer. O'Dwyer E; Bodei L; Morris MJ Semin Radiat Oncol; 2021 Jan; 31(1):71-82. PubMed ID: 33246638 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer. Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417 [TBL] [Abstract][Full Text] [Related]
14. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with Kratochwil C; Bruchertseifer F; Rathke H; Hohenfellner M; Giesel FL; Haberkorn U; Morgenstern A J Nucl Med; 2018 May; 59(5):795-802. PubMed ID: 29326358 [TBL] [Abstract][Full Text] [Related]
15. TheraP: a randomized phase 2 trial of Hofman MS; Emmett L; Violet J; Y Zhang A; Lawrence NJ; Stockler M; Francis RJ; Iravani A; Williams S; Azad A; Martin A; McJannett M; ; Davis ID BJU Int; 2019 Nov; 124 Suppl 1():5-13. PubMed ID: 31638341 [TBL] [Abstract][Full Text] [Related]
16. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Yamamichi G; Kato T; Watabe T; Hatano K; Uemura M; Nonomura N Anticancer Res; 2024 Mar; 44(3):879-888. PubMed ID: 38423627 [TBL] [Abstract][Full Text] [Related]
17. An Overview of Targeted Alpha Therapy with Morgenstern A; Apostolidis C; Kratochwil C; Sathekge M; Krolicki L; Bruchertseifer F Curr Radiopharm; 2018; 11(3):200-208. PubMed ID: 29732998 [TBL] [Abstract][Full Text] [Related]
18. Targeted Alpha Therapy with Thorium-227. Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907 [TBL] [Abstract][Full Text] [Related]
19. PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials. Ramnaraign B; Sartor O Oncologist; 2023 May; 28(5):392-401. PubMed ID: 36806966 [TBL] [Abstract][Full Text] [Related]
20. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy. Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]